US Stock MarketDetailed Quotes
HUMA Humacyte
- 4.318
- -0.082-1.87%
Trading May 2 12:49 ET
514.16MMarket Cap-4035P/E (TTM)
4.550High4.280Low562.94KVolume4.500Open4.400Pre Close2.45MTurnover0.69%Turnover RatioLossP/E (Static)119.08MShares5.60052wk High37.87P/B352.49MFloat Cap1.96052wk Low--Dividend TTM81.64MShs Float17.450Historical High--Div YieldTTM6.13%Amplitude1.960Historical Low4.349Avg Price1Lot Size
Humacyte Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -3.06%-73.31M | -0.50%-19.05M | 22.60%-13.01M | -36.42%-22.6M | 0.83%-18.64M | 12.39%-71.13M | 11.60%-18.96M | 44.94%-16.8M | -12.87%-16.57M | -29.25%-18.8M |
| Net income from continuing operations | -825.83%-110.78M | -574.89%-25.11M | -2.82%-26M | -161.59%-22.71M | -86.41%-36.97M | 54.81%-11.97M | -108.74%-3.72M | 19.90%-25.28M | 314.37%36.87M | 2.31%-19.83M |
| Operating gains losses | 756.69%2.7M | 120.47%35K | 101.49%135K | 1,167.38%2.49M | 156.76%42K | 87.69%-411K | -194.83%-171K | 3,250.00%67K | ---233K | ---74K |
| Depreciation and amortization | -5.98%7.72M | -13.29%1.83M | -10.07%1.83M | -1.88%1.98M | 1.62%2.07M | -0.38%8.21M | 3.32%2.11M | -1.17%2.04M | -2.18%2.02M | -1.45%2.04M |
| Other non cash items | 118.41%13.65M | 97.90%-353K | 55.59%2.2M | 95.07%-2.76M | 607.60%14.56M | -35.50%-74.18M | 74.27%-16.77M | -85.99%1.41M | -17,209.79%-55.95M | -16,038.89%-2.87M |
| Change In working capital | 538.58%6.57M | 250.53%3.13M | 102.32%7.05M | -350.07%-3.45M | -140.66%-159K | 284.74%1.03M | -33.85%-2.08M | 658.49%3.49M | -260.13%-767K | -65.76%391K |
| -Change in receivables | -78.62%31K | --0 | --0 | --0 | 154.39%31K | 330.16%145K | --0 | 182.85%1.27M | -100.00%-1.07M | -35.71%-57K |
| -Change in prepaid assets | -128.45%-388K | -93.66%35K | 2,175.00%3.24M | -2,689.04%-3.78M | -85.40%120K | 162.74%1.36M | 420.93%552K | 91.90%-156K | 278.05%146K | 11,642.86%822K |
| -Change in payables and accrued expense | 2,763.36%6.98M | 227.00%3.11M | 60.60%3.83M | 104.82%340K | 17.91%-298K | -114.25%-262K | -85.45%-2.45M | 175.49%2.38M | -84.98%166K | -130.56%-363K |
| -Change in other current liabilities | -11.11%-50K | -18.18%-13K | -8.33%-13K | -9.09%-12K | -9.09%-12K | -7.14%-45K | -10.00%-11K | -9.09%-12K | -10.00%-11K | 0.00%-11K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | -49.14%-173K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -3.06%-73.31M | -0.50%-19.05M | 22.60%-13.01M | -36.42%-22.6M | 0.83%-18.64M | 12.39%-71.13M | 11.60%-18.96M | 44.94%-16.8M | -12.87%-16.57M | -29.25%-18.8M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -103.57%-173K | -102.88%-150K | -133.65%-493K | 1,310.45%1.62M | -5,136.36%-1.15M | 158.94%4.85M | 164.79%5.21M | -154.22%-211K | -112.70%-134K | 24.14%-22K |
| Net PPE purchase and sale | -117.56%-2.28M | 77.97%-150K | -133.65%-493K | -261.94%-485K | -5,136.36%-1.15M | -376.36%-1.05M | -1,413.33%-681K | -154.22%-211K | -112.70%-134K | 24.14%-22K |
| Net investment purchase and sale | -64.25%2.11M | --0 | --0 | ---- | ---- | 173.66%5.89M | 173.66%5.89M | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -103.57%-173K | -102.88%-150K | -133.65%-493K | 1,310.45%1.62M | -5,136.36%-1.15M | 158.94%4.85M | 164.79%5.21M | -154.22%-211K | -112.70%-134K | 24.14%-22K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 411.69%4.51M | -58.02%-335K | -164.36%-764K | 1,342.77%6.02M | 11.28%-409K | -100.54%-1.45M | -103.24%-212K | -100.12%-289K | 47.16%-484K | -102.39%-461K |
| Net issuance payments of debt | -1,619.64%-34.07M | -13.51%-588K | -14.03%-577K | -6,440.00%-32.37M | -14.29%-528K | -107.09%-1.98M | -105.43%-518K | -14.22%-506K | -14.58%-495K | -102.40%-462K |
| Proceeds from stock option exercised by employees | 5.79%566K | -17.32%253K | -54.38%99K | 763.64%95K | 11,800.00%119K | -10.54%535K | 15,200.00%306K | -39.72%217K | -63.33%11K | -99.51%1K |
| Net other financing activities | --38.01M | --0 | ---286K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 411.69%4.51M | -58.02%-335K | -164.36%-764K | 1,342.77%6.02M | 11.28%-409K | -100.54%-1.45M | -103.24%-212K | -100.12%-289K | 47.16%-484K | -102.39%-461K |
| Net cash flow | ||||||||||
| Beginning cash position | -31.14%149.77M | -38.72%100.34M | -36.70%114.6M | -34.63%129.57M | -31.14%149.77M | 444.72%217.5M | -31.91%163.73M | 524.93%181.04M | 344.17%198.22M | 444.72%217.5M |
| Current changes in cash | -1.83%-68.97M | -39.97%-19.54M | 17.57%-14.26M | 12.92%-14.97M | -4.78%-20.2M | -138.14%-67.73M | 39.17%-13.96M | -108.18%-17.3M | -9.76%-17.19M | -510.30%-19.28M |
| End cash Position | -46.05%80.8M | -46.05%80.8M | -38.72%100.34M | -36.70%114.6M | -34.63%129.57M | -31.14%149.77M | -31.14%149.77M | -31.91%163.73M | 524.93%181.04M | 344.17%198.22M |
| Free cash flow | -4.72%-75.59M | 2.22%-19.2M | 20.66%-13.5M | -38.23%-23.09M | -5.18%-19.79M | 11.34%-72.18M | 8.62%-19.64M | 44.40%-17.02M | -13.29%-16.7M | -29.14%-18.82M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
